ID   UM-UC-16
AC   CVCL_2748
SY   UMUC16; University of Michigan-Urothelial Carcinoma-16
DR   Cell_Model_Passport; SIDM01404
DR   Cosmic; 1082654
DR   Cosmic; 1938711
DR   DepMap; ACH-001409
DR   ECACC; 08090510
DR   Wikidata; Q54990984
RX   PubMed=16469639;
RX   PubMed=19375735;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap; ECACC
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D21S11: 30,32
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22,24.2
ST   Penta D: 11,12
ST   Penta E: 13,17
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=16469639; DOI=10.1016/S0022-5347(05)00323-X;
RA   Sabichi A.L., Keyhani A., Tanaka N., Delacerda J., Lee I.-L., Zou C.-P.,
RA   Zhou J.-H., Benedict W.F., Grossman H.B.;
RT   "Characterization of a panel of cell lines derived from urothelial
RT   neoplasms: genetic alterations, growth in vivo and the relationship of
RT   adenoviral mediated gene transfer to coxsackie adenovirus receptor
RT   expression.";
RL   J. Urol. 175:1133-1137(2006).
//
RX   PubMed=19375735; DOI=10.1016/j.juro.2009.01.108;
RA   Chiong E., Dadbin A., Harris L.D., Sabichi A.L., Grossman H.B.;
RT   "The use of short tandem repeat profiling to characterize human
RT   bladder cancer cell lines.";
RL   J. Urol. 181:2737-2748(2009).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//